Prednisone and Ocular toxicity - a phase IV clinical study of FDA data

Summary:

Ocular toxicity is reported as a side effect among people who take Prednisone (prednisone), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Plaquenil, and have Systemic lupus erythematosus.

The phase IV clinical study analyzes which people have Ocular toxicity when taking Prednisone. It is created by eHealthMe based on reports of 628,814 people who have side effects when taking Prednisone from the FDA, and is updated regularly.

What is Prednisone?

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,827 Prednisone users. Check the latest studies of Prednisone.

What is Ocular toxicity?

Ocular toxicity (damages eye) is found to be associated with 65 drugs and 118 conditions by eHealthMe. Check the latest studies of Ocular toxicity.

On Jul, 14, 2026

628,814 people reported to have side effects when taking Prednisone.
Among them, 50 people (0.01%) have Ocular toxicity.

Among these 50 people:

How long have people been on Prednisone when they have Ocular toxicity? *

What is the gender of people who have Ocular toxicity when taking Prednisone? *

female: 95.35 %
male: 4.65 %

What is the age of people who have Ocular toxicity when taking Prednisone? *

What are other drugs people take besides Prednisone? *

What are other side effects people have besides Ocular toxicity? *

Drug Ineffective: 26 people, 52.00%
Swelling: 20 people, 40.00%
C-Reactive Protein Increased: 19 people, 38.00%
Abdominal Pain: 16 people, 32.00%
Eye Infection: 15 people, 30.00%
Skin Discoloration: 14 people, 28.00%
Vasculitic Rash (inflammation of a blood vessel or blood vessels with rashes under the skin): 14 people, 28.00%
Inflammation: 14 people, 28.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 14 people, 28.00%
Joint Swelling: 9 people, 18.00%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 16 people, 32.00%
Cutaneous Vasculitis (an inflammatory process affecting the vessel wall that leads to its damage): 14 people, 28.00%
Urinary Tract Infection: 2 people, 4.00%
Bladder Pain: 2 people, 4.00%
Cystitis Interstitial (unknown cause characterized by bladder pain): 2 people, 4.00%
Diabetes: 2 people, 4.00%
Food Allergy: 2 people, 4.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.00%
High Blood Pressure: 2 people, 4.00%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisone and have Ocular toxicity?

- Check whether Ocular toxicity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prednisone:

Prednisone (636,827 reports)

Browse all side effects of Prednisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ocular toxicity:

Ocular toxicity (65 drugs)

Browse all the conditions that are associated with Ocular toxicity:

Ocular toxicity (118 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prednisone (the active ingredients of Prednisone) and Prednisone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.